05.01.2022 13:00:00
|
BAUSCH HEALTH TO PARTICIPATE AT THE 40TH ANNUAL J.P. MORGAN HEALTHCARE CONFERENCE
LAVAL, QC, Jan. 5, 2022 /PRNewswire/ -- Bausch Health Companies Inc. (NYSE/TSX: BHC) today announced that Joseph C. Papa, chairman and chief executive officer, is scheduled to participate at the 40th Annual J.P. Morgan Healthcare Conference on Wednesday, Jan. 12, 2022 at 9:00 a.m. ET.
A live webcast and audio archive of the event will be available on the Investor Relations page of the Bausch Health Companies Inc. website at: https://ir.bauschhealth.com/events-and-presentations/2022.
About Bausch Health
Bausch Health Companies Inc. (NYSE/TSX: BHC) is a global company whose mission is to improve people's lives with our health care products. We develop, manufacture and market a range of pharmaceutical, medical device and over-the-counter products, primarily in the therapeutic areas of eye health, gastroenterology and dermatology. We are delivering on our commitments as we build an innovative company dedicated to advancing global health. For more information, visit www.bauschhealth.com and connect with us on Twitter and LinkedIn.
Investor Contact: | Media Contact: | |||
Arthur Shannon | Lainie Keller | |||
arthur.shannon@bauschhealth.com | lainie.keller@bauschhealth.com | |||
(514) 856-3855 | (908) 927-1198 | |||
(877) 281-6642 (toll free) |
View original content to download multimedia:https://www.prnewswire.com/news-releases/bausch-health-to-participate-at-the-40th-annual-jp-morgan-healthcare-conference-301454091.html
SOURCE Bausch Health Companies Inc.
Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu Bausch Healthmehr Nachrichten
29.10.24 |
Ausblick: Bausch Health stellt Quartalsergebnis zum abgelaufenen Jahresviertel vor (finanzen.net) | |
15.10.24 |
Erste Schätzungen: Bausch Health verkündet Quartalsergebnis zum jüngsten Jahresviertel (finanzen.net) | |
31.07.24 |
Ausblick: Bausch Health stellt Quartalsergebnis zum abgelaufenen Jahresviertel vor (finanzen.net) |
Analysen zu Bausch Healthmehr Analysen
Aktien in diesem Artikel
Bausch Health | 7,21 | -1,57% |